ETHE1 and ethylmalonic encephalopathy: Likewise, our results open realistic perspectives to the treatment of human EE, providing proof-of-principle, evidence-based demonstration that AAV-driven ETHE1 gene therapy is an effective and feasible approach, directly translatable to clinical practice.